December 16, 2025 · Form 4 insider transaction
Smith Andrew Alasdair bought 50,000 shares of Medicus Pharma Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
The option was granted on December 16, 2025. The option is scheduled to vest quarterly in four equal installments over one year.